MAZE
NA
Latest News for MAZE
In a report released yesterday, Salim Syed from Mizuho Securities maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $97.00......
In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $57.00. K......
In a report released today, Rami Katkhuda from LifeSci Capital maintained a Buy rating on Maze Therapeutics, Inc., with a price target of $57.00. K......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Maze Therapeutics, Inc. (MAZE), Azitra Inc (AZTR) ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma (ALNY), Biomea Fusion (BMEA) and Maze......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MAZE | $27.88 | 0% | 855.12K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |